When it comes to dosage and frequency, everyone is a little different
The compounds covered in this piece GHK-Cu, KPV, GLP-1 agonists, NAD precursors, glutathione, Thymosin Alpha-1, low-dose MOTS-c, DSIP, intermittent Semax and Selank, and Tesamorelin do not have a receptor desensitization mechanism that justifies the universal 8-on, 4-off rule
The figures below combine county and state sources for the most current numbers available
A., Unsal-Kamaz, K
Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa FRESHLY PREPARED SOLUTION CHONLUTEN - 50mg Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline
